Skip to content
ppharmaranks
Menu

Best treatments for hepatic encephalopathy

2 products may treat hepatic encephalopathy, spanning FDA drug classes such as osmotic laxative, aminoglycoside antibacterial. The current highest-rated option is lactulose. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 2 drugs we list for hepatic encephalopathy, all are available as lower-cost generics, spanning classes such as osmotic laxative, aminoglycoside antibacterial. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for hepatic encephalopathy — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Top-rated picks for hepatic encephalopathy: 1. Lactulose · 2. Neomycin Sulfate

Top-rated treatments for hepatic encephalopathy, ranked by pharmaranks score
#DrugRatingPharmacy pays
168/100$1View →
248/100$25View →

Full ranking · 2 treatments

Frequently asked

What treats hepatic encephalopathy?
Our catalog lists 2 products that may treat hepatic encephalopathy, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is lactulose.
What is the best-rated treatment for hepatic encephalopathy?
By our independent recall-safety rating — not an efficacy measure — lactulose ranks highest among the products we list for hepatic encephalopathy. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat hepatic encephalopathy?
Treatments for hepatic encephalopathy span FDA drug classes including osmotic laxative, aminoglycoside antibacterial. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.